UCB's Global Corporate Website

Investigator-Initiated Studies (IIS)

UCB is committed to supporting research that addresses important scientific questions aligned with UCB's therapeutic areas of interest.  UCB's Investigator-Initiated Studies (IIS) program supports independent research with the potential to enhance medical and scientific knowledge that is initiated, sponsored, and conducted by an investigator without influence from UCB.

UCB will also consider innovative ideas that enhance patient care and advance scientific knowledge.

UCB's support may be provided in the form of funding and/or investigational drugs (product or compound manufactured/owned by UCB).

Submitting a Concept
UCB is using the eRequest on-line submission portal to manage all Investigator-Initiated Study requests worldwide. To submit a concept, please click here.

An appropriate Review Committee will evaluate the submitted proposals. Depending on the therapeutic area, this review is performed monthly or bimonthly. If a concept is recommended for a full proposal submission, as IIS Team member will contact the applicant with further instructions.

Therapeutic Areas of Interest

Ankylosing Spondylitis     Parkinson's disease
Axial Spondyloarthritis Psoriatic Arthritis
Chron's disease Restless Legs Syndrome
Epilepsy     Rheumatoid Arthritis
Low Bone Mass Disorder     Systemic Lupus Erythematosus

Contact us

To submit a IIS application access eRequest.

Contact us:  IIS_support@ucb.com

For Australia & China kindly contact the UCB Medical Affairs department in your country for assistance.